Case no.
|
Sex / Age
|
Tumor location (Synchron./Metachron.)
|
WHO-Grade
|
Stage
|
Instable markers
|
Immunohistochemical expression
|
---|
| | | | | |
MLH1
|
MSH2
|
MSH6
|
PMS2
|
---|
U1-113
|
F/54
|
ureter
|
G2
|
pTX
|
NE
|
+
|
-
|
-
|
+
|
|
53
|
endometrium (M)
| | |
4/6
|
+
|
-
|
-
|
+
|
U2-229
|
F/57
|
ureter
|
G2
|
pT1
|
4–5/6
|
-
|
+
|
+
|
-
|
|
57
|
ureter (S)
| | |
4–5/6
|
-
|
+
|
+
|
-
|
U3-821
|
M/61
|
ureter*
|
G2
|
pT1
|
2–3/6
|
+
|
-
|
-
|
+
|
RP1-101
|
M/60
|
renal pelvis
|
G2
|
pT3
|
3/5
|
+
|
-
|
-
|
+
|
|
43
|
sarcoma (M)
| | |
3/4
|
+
|
-
|
-
|
+
|
|
53
|
colon (M)
| | |
1/6¤
|
+
|
-
|
-
|
+
|
RP2-131
|
M/75
|
renal pelvis
|
G3
|
pT4
|
2/6
|
+
|
+
|
+
|
+
|
RP3-119
|
F/69
|
renal pelvis
|
G3
|
pTa
|
0/6
|
-
|
+
|
NE
|
-
|
RP4-267
|
F/67
|
renal pelvis
|
G2
|
pT1
|
5/5
|
+
|
-
|
-
|
+
|
|
70
|
urinary bladder (M)
| | |
3/4
|
+
|
-
|
-
|
+
|
RP5-401
|
M/56
|
renal pelvis
|
G2
|
pTa
|
0/6
|
+
|
+
|
-
|
+
|
RP6-528
|
F/87
|
renal pelvis
|
G2
|
pT1
|
2/5
|
+
|
+
|
+
|
+
|
|
87
|
urinary bladder (S)
| | |
0/6
|
+
|
+
|
+
|
+
|
RP7-613
|
F/57
|
renal pelvis^
|
G2
|
pT1
|
3/6
|
+
|
+
|
-
|
+
|
|
54
|
urinary bladder (M)
| | |
4/6
|
+
|
-
|
-
|
+
|
RP8-626
|
M/66
|
renal pelvis
|
G3
|
pT2
|
6/6
|
+
|
-
|
-
|
+
|
RP9-701
|
F/49
|
renal pelvis#
|
G2
|
pTa
|
0/5
|
+
|
-
|
NE
|
+
|
RP10-809
|
F/82
|
renal pelvis
|
G3
|
pT4
|
4/4
|
+
|
-
|
-
|
+
|
- ¤Positive for BAT26
- * Myelofibrosis at the age of 67 years.
- ^Cervical cancer at the age of 33.
- # Rectal tumor at the age of 38.
- G2 moderately differentiated
- G3 poorly differentiated